为您找到相关结果约500个

你是不是要搜索 期刊Bempedoic酸这种非他汀类调脂药在服用最大耐受剂量他汀类药物的基础上可进一步降低LDL-C20+mg/dl。在他汀类药物不耐受患者中可降低37+mg/dl。 点击跳转

Better Atheroma Regression for LDL Cholesterol < 70 mg/dl

LDL-C Levels Below 55 mg/dl and Risk of Hemorrhagic Stroke: A Meta-Analysis

The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, whenLDL-C is less than 104 mg/dL

LDL Cholesterol >= 190 mg/dl: Primary Prevention seems to be useful

Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C > 100 mg/dl

The frontier of very low (< 30 mg/dL) LDL cholesterol

IDENTIFICATION AND EVALUATION OF PATIENTS WITH LDL-C >=190 MG/DL AT A TERTIARY ACADEMIC CENTER

More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke

RISK STRATIFICATION BY CORONARY ARTERY CALCIFICATION IN PATIENTS WITH LDL > 190 MG/DL

The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose

THE EVALUATION AND MANAGEMENT OF PATIENTS WITH LDL-C >=190 MG/DL IN A LARGE HEALTH CARE SYSTEM

ALIROCUMAB IN HIGH-RISK PATIENTS WITH BASELINE LDL-C >= 160 MG/DL: FINDINGS FROM THE COMPASSIONATE USE

Statins Effective for LDL 190 mg per dL or Higher, Regardless of Risk Level

Baseline LDL-cholesterol levels below 70 mg/dl and statin treatment in acute ischemic stroke

coronary revascularization events in patients undergoing percutaneous coronary intervention with baseline LDL-C<55 mg/dL

为您找到相关结果约500个

共500条页码: 1/34页15条/页